Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid Leukemia.
Journal: Cancer research communications
Published: January 13, 2026
Harnessing p97/VCP: A Transformative AAA+ ATPase Target for Next-Generation Cancer Therapeutics.
Journal: Cancers
Published: July 16, 2025
Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.
Journal: Cancers
Published: April 11, 2025
DeepDeconUQ estimates malignant cell fraction prediction intervals in bulk RNA-seq tissue.
Journal: PLoS computational biology
Published: November 15, 2024
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 26, 2024
Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangement.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: August 02, 2024
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial.
Journal: Leukemia
Published: February 14, 2024
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 14, 2023
DeepDecon accurately estimates cancer cell fractions in bulk RNA-seq data.
Journal: Patterns (New York, N.Y.)
Published: September 26, 2023
Incidence of Venous Thromboembolism Among Commonly Prescribed Second-Generation Antipsychotics.
Journal: Journal of pharmacy practice
Published: June 22, 2023
Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 07, 2023
Last Updated: 09/26/2026